Kommentar zu „Antidepressiva als Schmerzmittel selten geeignet“

• Literatur

• 1 Desfaye S. et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 2022; 400: 680-690
• 2 Moore RA. et al. “Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews. Pain 2010; 150: 386-389
• 3 Obata H. Analgesic Mechanisms of Antidepressants for Neuropathic Pain. Int J Mol Sci 2017; 18: 2483
• 4 Cagnie B. et al. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum 2014; 44: 68-75
• 5 Mayer EA. et al. The neurobiology of irritable bowel syndrome. Mol Psychiatry 2023;